In summary, the exosomal lncRNA RUNX2-AS1 derived from MM cells acts as a natural antisense transcript of RUNX2 and directly binds to and downregulates the expression of RUNX2 in bone marrow stromal cells, thereby inhibiting bone formation. Here, RUNX2 is linked to Miyoshi myopathy.